Single-oral-dose azithromycin prophylaxis against experimental streptococcal or staphylococcal aortic valve endocarditis

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 6, 2000, Pages 1754-1756

  Tsitsika, Artemis ^a   Pefanis, Angelos ^a   Perdikaris, George S ^a   Donta, Ismini ^a   Karayiannakos, Panayiotis ^a   Helen, Giamarellou ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZITHROMYCIN; METICILLIN; VANCOMYCIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC PROPHYLAXIS; AORTA VALVE DISEASE; ARTICLE; BACTERIAL ENDOCARDITIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG TISSUE LEVEL; FEMALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; STREPTOCOCCUS ORALIS;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; AORTIC VALVE; AZITHROMYCIN; ENDOCARDITIS, BACTERIAL; FEMALE; RABBITS; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS;

EID: 0034120558     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.6.1754-1756.2000     Document Type: Article

References (15)

1. Berney, P., and P. Francioli. 1990. Successful prophylaxis of experimental streptococcal endocarditis with single-dose amoxicillin administered after bacterial challenge. J. Infect. Dis. 161:281-285.
2. Cars, O., and S. Ogren. 1981. A microtechnique for the determination of antibiotics in muscle. J. Antimicrob. Chemother. 8:39-48.
3. Dajani, A. S., K. A. Taubert, W. Wilson, A. F. Bolger, A. Bayer, P. Ferrieri, M. H. Gewitz, S. T. Shulman, S. Nouri, J. W. Newburger, C. Hutto, T. J. Pallasch, T. W. Gage, M. E. Levison, G. Peter, and G. Zuccaro. 1997. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 277:1794-1801.
4. Durack, D. T. 1995. Prevention of infective endocarditis. N. Engl. J. Med. 332:38-44.
5. Foulds, G., R. M. Shepard, and R. B. Johnson. 1990. The pharmacokinetics of azithromycin in human serum and tissues. J. Antimicrob. Chemother. 25(Suppl. A):73-82.
6. Girant, A. E., D. Girant, A. R. English, T. D. Gootz, C. R. Cimochowski, J. A. Faiella, S. L. Haskell, and J. A. Retsema. 1987. Pharmacokinetic and in vivo studies with azithromycin (CP-62993), a new macrolide with an extended half-life and excellent tissue distribution. Antimicrob. Agents Chemother. 31:1948-1954.
7. Girard, A. E., C. R. Cimochowski, and J. A. Faiella. 1993. The comparative activity of azithromycin, macrolides and amoxycillin against streptococci in experimental infections. J. Antimicrob. Chemother. 31(Suppl. E):29-37.
8. Hardy, D. J., D. M. Hensey, J. M. Beyer, C. Vojtko, E. J. McDonald, and P. B. Fernandes. 1988. Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrob. Agents Chemother. 32:1710-1719.
9. Heraief, E., M. P. Glauser, and L. R. Freedman. 1980. Vancomycin prophylaxis of streptococcal endocarditis in rats, p. 911-913. In J. D. Nelson and C. Grassi (ed.), Current chemotherapy and infectious diseases, vol. 2. American Society for Microbiology, Washington, D.C.
10. Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339: 520-532.
11. Moreillon, P., P. Francioli, D. Overholser, P. Meylan, and M. P. Glauser. 1986. Mechanisms of successful amoxicillin prophylaxis of experimental endocarditis due to Streptococcus intermedius. J. Infect. Dis. 154:801-807.
12. Perdikaris, G. S., A. Pefanis, H. Giamarellou, A. Nikolopoulos, E. P. Margaris, I. Donta, A. Tsitsika, and P. Karayiannakos. 1997. Successful single-dose teicoplanin prophylaxis against experimental streptococcal, enterococcal, and staphylococcal aortic valve endocarditis. Antimicrob. Agents Chemother. 41:1916-1921.
13. Perlman, B. B., and L. R. Freedman. 1971. Experimental endocarditis. II. Staphylococcal infections of the aortic valve following placement of a polyethylene catheter in the left side of the heart. Yale J. Biol. Med. 44:206-221.
14. Rouse, M. S., J. M. Steckelberg, C. M. Brandt, R. Patel, J. M. Miro, and W. R. Wilson. 1997. Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis. Antimicrob. Agents Chemother. 41:1673-1676.
15. van der Meer, J. T. M., W. van Wijk, J. Thomson, J. P. Vandenbroucke, H. A. Valkenburg, and M. F. Michel. 1992. Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis. Lancet 339:135-139.